Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-02 9:00 pm Sale | 2026-06-02 | 13D | BLUEJAY DIAGNOSTICS INC PA BJDX | NorthStrive Fund II LP | 0 0.000% | -35,500 (Position Closed) | Filing History |
| 2026-03-11 08:12 am Unchanged | 2026-03-11 | 13D | BLUEJAY DIAGNOSTICS INC PA BJDX | NorthStrive Fund II LP | 35,500 3.650% | 0 (Unchanged) | Filing History |
| 2026-03-11 06:40 am Unchanged | 2026-03-11 | 13D | BLUEJAY DIAGNOSTICS INC PA BJDX | NorthStrive Fund II LP | 35,500 3.650% | 0 (Unchanged) | Filing History |
| 2026-02-20 09:43 am Unchanged | 2026-02-20 | 13D | ENVVENO MED CORP COM NVNO | NorthStrive Fund II LP | 33,151 5.050% | 0 (Unchanged) | Filing History |
| 2026-02-10 4:29 pm Purchase | 2026-02-10 | 13G | ENVVENO MED CORP COM NVNO | NorthStrive Fund II LP | 33,151 5.050% | 33,151 (New Position) | Filing History |
| 2026-02-05 9:43 pm Purchase | 2026-02-05 | 13G | BLUEJAY DIAGNOSTICS INC PA BJDX | NorthStrive Fund II LP | 35,500 5.010% | 35,500 (New Position) | Filing History |
| 2025-12-10 3:47 pm Sale | 2025-12-09 | 13G | ENVERIC BIOSCIENCES INC OC ENVB | NorthStrive Fund II LP | 0 0.000% | -29,920 (Position Closed) | Filing History |
| 2025-12-05 5:40 pm Purchase | 2025-12-03 | 13G | ENVERIC BIOSCIENCES INC OC ENVB | NorthStrive Fund II LP | 29,920 5.010% | 29,920 (New Position) | Filing History |